We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Oxytocin and Social Behavior Over the Lifespan

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00914953
Recruitment Status : Completed
First Posted : June 5, 2009
Last Update Posted : March 2, 2012
Information provided by (Responsible Party):
Paul J. Zak, Claremont Graduate University

Brief Summary:
This study will investigate if intranasal oxytocin (a hormone naturally produced in the body) promotes motivation for, and engagement in, social activities in older adults.

Condition or disease Intervention/treatment Phase
Social Activity Drug: oxytocin (Pitocin) Early Phase 1

Detailed Description:
Using a double-blind and placebo controlled design, this study seeks to determine if a short course of exogenous oxytocin (OT) will induce changes in social activities in residentially housed older adults (OAs) during a 10-day treatment period, and after it ends. Because OT is associated with peri-reproductive behaviors, OT release in OAs is expected to be attenuated relative to younger adults. If OT release is low in OAs as we hypothesize, augmenting OT may increase their desire for social interactions, increase the frequency of participation in social activities and augment the number of and quality of social ties, thereby providing protection against disease, early death, cognitive decline, and depression. Research in rodents suggests that social interactions themselves may change chronic OT levels (Carter & Keverne, 2002; Carter & Altemus, 1997), in a positive feedback loop. In order to demonstrate OT as the causal mechanism, we propose to infuse oxytocin and then track the desire for, quantity of, and quality of social activities.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 41 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Basic Science
Official Title: Oxytocin and Social Behavior Over the Lifespan: Interventional Study
Study Start Date : February 2010
Primary Completion Date : December 2010
Study Completion Date : December 2011

Resource links provided by the National Library of Medicine

Drug Information available for: Oxytocin
U.S. FDA Resources

Arm Intervention/treatment
Experimental: oxytocin Drug: oxytocin (Pitocin)
40 IU OT intranasally (IN) once-daily for 10 consecutive days

Primary Outcome Measures :
  1. confirm increased social activities in treatment condition compared to control condition via self-report. [ Time Frame: 30 days ]

Secondary Outcome Measures :
  1. Evidence of greater psychological health for treatment condition as compared to control condition. [ Time Frame: 30 days ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   50 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • residentially housed
  • English fluency

Exclusion Criteria:

  • non ambulatory
  • severe psychiatric problems presently or in the recent past
  • severe medical problems (e.g., cancer, diabetes, advanced heart disease)
  • irregular heart beat
  • treatment using psychoactive medications (other than antiepileptics, mood stabilizers, or Ambien)
  • inability to adequately communicate with the research team
  • treatment with an experimental drug
  • excessive fatigue suggesting hypothyroidism

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00914953

United States, California
Linda Valley Villa
Loma Linda, California, United States, 92354-3135
Sponsors and Collaborators
Claremont Graduate University

Responsible Party: Paul J. Zak, Professor, Claremont Graduate University
ClinicalTrials.gov Identifier: NCT00914953     History of Changes
Other Study ID Numbers: CNS-R21AG029871
NIH Grant 1R21AG029871-01A2
First Posted: June 5, 2009    Key Record Dates
Last Update Posted: March 2, 2012
Last Verified: February 2012

Keywords provided by Paul J. Zak, Claremont Graduate University:
social isolation
cooperative behavior

Additional relevant MeSH terms:
Reproductive Control Agents
Physiological Effects of Drugs